Supriya Lifescience Limited
₹655-1.15%Feb 27, 3:45 PM IST
SUPRIYA•Health Technology•Pharmaceuticals: Major
Current Price
₹655-1.15%
Feb 27, 3:45 PM ISTMarket Cap₹5,336.01 Cr
Market Cap₹5,336.01 Cr
Business Overview
Supriya Lifescience Limited operates through 3 main business divisions including Active Pharmaceutical Ingredients (APIs), Formulations, Contract Development and Manufacturing Organization (CDMO) Services.
Business Hierarchy Structure for Supriya Lifescience Limited
- Supriya Lifescience Limited
- Active Pharmaceutical Ingredients (APIs)
- Therapeutic Areas
- Analgesic/Anesthetic
- Ketamine Hydrochloride
- Enzalutamide
- Pentobarbital sodium
- Semaglutide
- Ruxolutinib
- Ibrutinib
- Dexmedetomidine hydrochloride
- Anti-histamine
- Brompheniramine Maleate
- Chlorphenamine Maleate
- Cetirizine dihydrochloride
- Vitamins
- Mecobalamin
- Riboflavin
- Anti-asthmatic
- Salbutamol Sulphate
- Anti-allergic
- Dex Chlorpheniramine
- Other Therapeutic Areas (Portfolio Expansion)
- Anti-depressants
- Anti-anxiety medications
- Anti-convulsants
- Hypnotic therapies
- Analgesic/Anesthetic
- Other Specialized APIs
- Pentoxifylline
- Sodium phosphate
- N-benzyl salbutamol
- Therapeutic Areas
- Formulations
- Oral Solid Dosages (OSD)
- Liquid Inhalers
- Injectables
- Contract Development and Manufacturing Organization (CDMO) Services
- Active Pharmaceutical Ingredients (APIs)